Singulus Technologies (SNG) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
29 Jul, 2026Executive summary
Revenues increased to €21.8 million in Q1-2026 from €16.4 million in Q1-2025, with order intake rising sharply to €28.8 million from €6.4 million year-over-year.
EBIT improved to €2.2 million in Q1-2026 from €0.5 million in Q1-2025, and net result turned positive at €1.3 million versus a loss of €0.3 million.
Order backlog increased to €69.5 million as of March 31, 2026.
For full year 2025, net revenue was €48.2 million, down from €75.8 million in 2024, with a net loss of €14.2 million and negative EPS of €1.60.
Strategic cooperation and refinancing agreements were concluded, strengthening financial stability.
Financial highlights
Gross profit margin in Q1-2026 was 36.0%, up from 34.6% in Q1-2025.
Operating cash flow in Q1-2026 was negative at €-1.5 million, but total cash flow was positive at €0.9 million due to financing activities.
Cash and cash equivalents increased to €7.0 million at the end of Q1-2026 from €6.2 million at year-end 2025.
Shareholders' equity remained negative at €-62.1 million at Q1-2026 end.
Revenue, EBIT, and order intake all showed strong year-over-year growth.
Outlook and guidance
Sales are expected to rise to approximately €83.0 million in 2026, up from €48.3 million in 2025.
EBIT is forecast to be positive in the low single-digit million range for 2026.
Revenue distribution in 2026 is projected at ~50% Solar, ~25% Semiconductor, and ~25% Life Science, or a 2:1:1 ratio.
Strategic collaboration with a leading technology company in the Solar segment is expected to drive growth.
Latest events from Singulus Technologies
- 2025 saw revenue fall to €48.3M and EBIT to -€11.7M, but 2026 outlook is positive after refinancing.SNG
Q4 202529 Jul 2026 - 2024 revenue grew, but EBIT stayed negative; outlook hinges on new orders and liquidity.SNG
Q4 202429 Jul 2026 - Order intake doubled and gross margin rose, but sales guidance was cut amid ongoing risks.SNG
Q2 202429 Jul 2026 - Revenue and orders fell, but margin improved; outlook positive amid ongoing risks.SNG
Q1 202529 Jul 2026 - Sales, EBIT, and order intake rose, but liquidity and going concern risks remain.SNG
Q3 202429 Jul 2026 - Revenue and orders fell sharply, resulting in losses and heightened liquidity risks.SNG
Q2 202529 Jul 2026 - Sales, EBIT, and order intake fell sharply; refinancing is critical by mid-2026.SNG
Q3 202529 Jul 2026